Abstract
Background
SARS-CoV2 infection has affected many older people and has required us to adapt our practices to this new pathology. Initial functional capacity is already considered an important prognostic marker in older patients particularly during infections.
Aim
The objective of this longitudinal study was to determine whether baseline functional disability was associated with mortality risk after 1 year in older patients hospitalized for COVID-19.
Methods
All COVID-19 patients admitted to the geriatric acute care unit of Angers University Hospital, France, between March-June 2020 received a group iso-ressource (GIR) assessment upon admission. Disability was defined as a GIR score≤3. All-cause mortality was collected after 1 year of follow-up. Covariables were age, sex, history of malignancies, hypertension, cardiomyopathy, number of acute diseases at baseline, and use of antibiotics or respiratory treatments during COVID-19 acute phase.
Results
In total, 97 participants (mean±SD 88.0+5.4 years; 49.5% women; 46.4% GIR score≤3) were included. 24 of the 36 patients who did not survive 1 year had a GIR score ≤ 3 (66.7%; P = 0.003). GIR score≤3 was directly associated with 1-year mortality (fully adjusted HR = 2.27 95% CI: 1.07–4.89). Those with GIR≤3 at baseline had shorter survival time than the others (log-rank P = 0.0029).
Conclusions
Initial functional disability was associated with poorer survival in hospitalized frail elderly COVID-19 patients.
Clinical trial registration
ClinicalTrials.gov: NCT04560608 registered on September 23, 2022
Publisher
Public Library of Science (PLoS)
Reference34 articles.
1. WHO Coronavirus (COVID-19) Dashboard. [cited 31 Jan 2022]. Available: https://covid19.who.int
2. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020. [cited 16 Jan 2021]. Available: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020
3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention;Z Wu;JAMA,2020
4. A Geroscience Perspective on COVID-19 Mortality;DEL Promislow;J Gerontol A Biol Sci Med Sci,2020
5. Coronavirus: chiffres clés et évolution de la COVID-19 en France et dans le Monde. [cited 31 Jan 2022]. Available: https://www.santepubliquefrance.fr/dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolution-de-la-covid-19-en-france-et-dans-le-monde